1. Home
  2. DERM vs WEA Comparison

DERM vs WEA Comparison

Compare DERM & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DERM

Journey Medical Corporation

HOLD

Current Price

$6.40

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Bond Fund Share of Beneficial Interest

WEA

Western Asset Bond Fund Share of Beneficial Interest

HOLD

Current Price

$10.64

Market Cap

125.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
WEA
Founded
2014
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.3M
125.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DERM
WEA
Price
$6.40
$10.64
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.67
N/A
AVG Volume (30 Days)
256.8K
33.7K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
7.87%
EPS Growth
34.72
N/A
EPS
N/A
N/A
Revenue
$61,858,000.00
N/A
Revenue This Year
$39.72
N/A
Revenue Next Year
$63.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.20
N/A
52 Week Low
$4.31
$10.30
52 Week High
$9.56
$11.44

Technical Indicators

Market Signals
Indicator
DERM
WEA
Relative Strength Index (RSI) 64.73 51.90
Support Level $4.84 $10.48
Resistance Level $6.71 $10.72
Average True Range (ATR) 0.40 0.09
MACD 0.08 0.01
Stochastic Oscillator 85.90 81.82

Price Performance

Historical Comparison
DERM
WEA

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About WEA Western Asset Bond Fund Share of Beneficial Interest

Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The fund invests in bonds of companies operating in different sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.

Share on Social Networks: